TPG-backed AHH picks controlling stake in Asian Institute of Nephrology & Urology for Rs 600 crore
The acquisition marks AHH’s foray into the urology and nephrology segment. AHH focuses on single specialty, since its launch in 2017, it has acquired single specialty chains such as CTSI (oncology), Motherhood Hospitals (women and child health), and Nova IVF (infertility).
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: Biotechnology | Cancer & Oncology | Children | Hospitals | Infertility | Mergers and Aquisitions | Pharmaceuticals | Reproduction Medicine | Urology & Nephrology | Women